Cantitate/Preț
Produs
Total produse
Vezi coșul
Improving the Regulatory Review Process: Industry and Regulatory Initiatives de C. Lumley

Improving the Regulatory Review Process: Industry and Regulatory Initiatives: Centre for Medicines Research Workshop

Editat de C. Lumley, S.R. Walker
en Limba Engleză Paperback – 20 sep 2011
Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process is made as efficient as possible. The 11th CMR Workshop, held in September 1995, provided the opportunity for regulatory authority and industry personnel from Europe, North America, Australia and Japan to openly discuss views and exchange experiences on the subject of improving the review process. The proceedings of this meeting provide a comprehensive overview of the current review process around the world. The contributors describe the present situation and highlight company strategies and regulatory initiatives to improve the review process. This volume also summarises the suggestions that were developed by the participants, covering many facets of this process, including the quality and size of the dossier, dialogue, submission strategies, feedback and the response to questions.
Citește tot Restrânge

Din seria Centre for Medicines Research Workshop

  • 5% Improving the Regulatory Review Process: Assessing Performance and Setting Targets
    Preț: 34912 lei
  • 5% The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines: Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993
    Preț: 35403 lei
  • 5% Long-Term Animal Studies: Their Predictive Value for Man
    Preț: 135592 lei

Preț: 104669 lei

Preț vechi: 110177 lei
-5%

Puncte Express: 1570
Preț estimativ în valută:
18507€ • 21838$ • 16207£

Carte tipărită la comandă

Livrare economică 13-27 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9789401072977
ISBN-10: 9401072973
Pagini: 196
Ilustrații: XX, 172 p.
Dimensiuni: 155 x 235 x 10 mm
Greutate: 0.29 kg
Ediția:Softcover reprint of the original 1st ed. 1996
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Centre for Medicines Research Workshop

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

1 International regulatory review times.- 2 What determines speed of review: Need for the product, quality of the dossier or efficiency of regulatory authorities?.- 3 Company strategies to ensure a quick and efficient review: Abiotech company.- 4 Company strategies to ensure a quick and efficient review: A Japanese company.- 5 Company strategies to ensure a quick and efficient review: A transnational company.- 6 Conditional licensing: Advantages and disadvantages.- 7 Dialogue and interaction between regulators and sponsors: Formal, informal or none at all?.- 8 The use of electronic dossiers or CANDAs: Help or hindrance?.- 9 The exchange of assessment reports and training of assessors.- 10 The regulatory assessment report in the new European system.- 11 Industry expert reports: An aid to the reviewer?.- 12 The use of internal and external experts and advisory boards: The European experience.- 13 Highlights of the Pharmaceutical Research and Manufacturers Association proposal for FDA reform.- 14 Suggestions that might be considered for improving the review process.- 15 The ideal future regulatory system: An industry perspective.- 16 What strategies should be considered forimplementation by the end of the century? MHW perspective.- 17 What strategies should be considered for implementation by the end of the century? European perspective.- 18 What strategies should be considered for implementation by the end of the century? CBER vision.- Meeting participants.